MedPath

Patterns of Urinary Bladder Cancer in Darfur, Suda

Completed
Conditions
Urinary Bladder Cancer
Registration Number
NCT06156787
Lead Sponsor
National Center for Gastroentestinal and Liver Disease
Brief Summary

Background: Bladder cancer (BC) exhibits extreme heterogeneity regarding clinical outcome, etiology, histology, and geographic distribution. Recent clinical observations point to alterations in the BC pattern in the Sudan, possibly as a result of lifestyle changes brought on by the enormous migration from rural to urban locations. This study aimed to identify the pattern of bladder cancer in Darfur.

Patients and Methods: A cross sectional, hospital-based study, it was conducted inNyala specialized hospital, during the period from (2020 to 2022), included one hundred and five patients with bladder mass matching the inclusion criteria were studied over the diversity of demographic data , clinical finding, pathological type and possible risk factors .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • All Sudanese pts who lives in Darfur and presented with urinary bladder mass.
  • Adult above 18 years
Exclusion Criteria
  • Patient who does not live in Darfur.
  • Patients refused to participate in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patterns of Urinary Bladder Cancer in Darfur, SudanThe research is a cross-sectional, hospital-based study conducted at Nyala Specialized Hospital in Darfur. The study spans a period from 2020 to 2022.

This research study investigates the patterns of urinary bladder cancer (BC) in Darfur, Sudan, with a focus on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nyala specialized hospital

🇸🇩

Darfur, Sudan

© Copyright 2025. All Rights Reserved by MedPath